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OCCUPATIONAL ASTHMA: WHAT ARE THE MECHANISMS? 
Mirjana Arandjelović and Jovica Jovanović 
Occupational asthma may be defined as asthma induced by acquired hypersensitivity to an 
agent inhaled at work. A lot of agents in the workplace have been shown to cause asthma and the 
list is growing as new materials and processes are introduced. There are two major types of 
occupational asthma. Sensitizer-induced asthma is characterized by specific responsiveness to the 
etiologic agent. The mechanism of irritant-induced asthma is unknown, but there is no clinical 
evidence of sensitization. Two other mechanisms by which variable airway obstruction due to 
workplace exposure can occur are reflex and pharmacological bronchoconstriction. Occupational 
asthma can be a challenging diagnosis to make and to prove. Tests which are used and are helpful 
include nonspecific pulmonary function tests, specific or bronchoprovocative pulmonary function 
test, serial pulmonary function tests (most commonly using the peak flow meter), and 
immunologic tests. Each test has its own drawbacks and none is perfect. Early diagnosis of 
occupational asthma and early removal of patients from exposure are important. Acta Medica 
Medianae 2003; 42 (3): 53-57. 
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Introduction 
Asthma is characterized by airway obstruction 
that is reversible either spontaneously or with treatme-
nt, airway inflammation, and increased airway respon-
siveness to variety of stimuli. In occupational asthma, 
there is variable airway obstruction and/or airway hy-
perresponsiveness due to workplace exposure(s). 
Work-related variable airway obstruction can be cau-
sed by several mechanisms, including type I-immune 
reactions, pharmacological effects, inflammatory pro-
cesses, and directs airway irritation. Many agents in the 
workplace have been shown to cause asthma and the list 
is growing as new materials and processes are intro-
duced. Work-aggravated asthma occurs when workpla-
ce exposures lead to exacerbation's of preexisting 
nonoccupational asthma. 
There are two major types of occupational 
asthma. Sensitizer-induced asthma is characterized by a 
variable time during which "sensitization" to an agent 
present in the work site takes place. Irritant-induced 
asthma occurs without a latent period after substantial 
exposure to an irritating dust, mist, vapor, or fume. Re-
active airways dysfunction syndrome (RADS) is a term 
used by some to describe irritant-induced asthma 
caused by a short-term, high-intensity exposure. 
Sensitizing agents known to cause occupational 
asthma can be divided into high-molecular weight 
(> 1000 Dalton) and low-molecular-weight compounds 
Table I. Some agents causing occupational asthma 
Mechanism  Examples 
Without "sensitization" 
Anticholinesterase effect 
Endotoxin effects 
Airway inflammation 
Airway irritation 
Organophosphate pesticide 
(agricultural workers) 
Cotton dust (textile workers) 
Acids, ammonia, chlorine 
(custodial workers, paper 
manufacturing workers) 
Dusts, fumes mists, vapors, 
cold (construction workers, 
chemical workers) 
With "sensitization" 
High-molecular-weight 
agents 
IgE-mediated 
(complete allergens) 
Low-molecular-weight 
agents 
IgE-mediated (haptens) 
Mechanisms undefined 
Animal and plant proteins 
(laboratory workers, Bakers) 
Antibiotics, metals (pharma-ce-
utical workers, metal plating 
workers, Acid anhydrides, di-
socyanates, plicatic acid 
(epoxy 
plastics and paints, polyure-
thane foams and paints, 
western red cedar products) 
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High molecular-weight compounds tend to cause 
occupational asthma via type I immunoglobulin E-
mediated reactions, whereas the mechanism(s) of low-
molecular-weight compounds is currently unknown. 
Sensitizer-induced asthma is characterized by specific 
responsiveness to the etiologic agent. The mechanism 
of irritant-induced asthma is unknown, but there is no 
clinical evidence of sensitization. Irritant-induced 
asthma involves persistent nonspecific airway 
hyperresponsiveness but not specific responsiveness to 
an etiologic agent. While there is no doubt that irritant-
induced asthma can be caused by a single intense 
exposure (i.e., RADS), it appears that lower-level 
exposure over a longer duration of time (months to 
years) can also cause the disease (1,2). 
Pathophysiology 
Airway inflammation is now recognized as the 
paramount feature of asthma. Asthmatic airways are 
characterized by (1) infiltration with inflammatory 
cells, especially eosinophils; (2) edema; and (3) loss of 
epithelial integrity. Airway obstruction in asthma is 
believed to be the result of changes associated with 
airway inflammation. Airway inflammation is also 
believed to play an important role in the genesis of 
airway hyperresponsiveness (2,3,4). 
Most of the research on mechanisms that mediate 
airway inflammation in asthma has focused on high-
molecular-weight allergen-induced responses. In a 
previously sensitized individual, inhalation of specific 
allergen allows interaction of the allergen with airway 
cells (mast cells and alveolar macrophages) that have 
specific antibodies (usually IgE) on the cell surface. 
This interaction initiates a series of redundant 
amplifying events that lead to airway inflammation. 
These events include mast cell secretion of mediators, 
lymphocyte interaction, and eosinophil recruitment to 
the airways. The generation and release of various 
cytokines from alveolar macrophages, mast cells, 
sensitized lymphocytes, and bronchial epithelial cells 
are central to the inflammatory process (figure 1). 
Cytokine networking, with both enhancing and 
inhibitory feedback loops, is responsible for inflamma-
tory cell targeting to the bronchial epithelium, activa-
tion of infiltrating cells, and potential amplification of 
epithelial injury. Adhesion molecules also play critical 
roles in the amplification of the inflammatory process. 
The expression of various adhesion molecules is 
unregulated during the inflammatory cascade, and 
these molecules are essential for cell movement, cell 
attachment to the extracellular matrix and other cells, 
and possibly cell activation. As noted above, the me-
chanism of low-molecular-weight sensitiyer-induced 
asthma is not well understood, although bronchial 
biopsy studies of affected workers have clearly demo-
nstrated that airway inflammation is present. 
Inhalation of the specific etiologic agent in a 
worker with sensitizer-induced asthma will often tri-
gger rapid-onset but self-limited bronchoconstriction. 
In many sensitized workers, a delayed reaction will 
occur 4-8. hours later, called the late response. Airway 
Figure I. Proposed pathways in the pathogenesis of asthma 
inflammation, persistent airway obstruction, and 
airway hyperesponsiveness characterize the late 
response. In some workers there is a dual response, and 
in others, only an isolated late response. Mast cell 
degranulation and release of mediators such as 
histamine are believed to be responsible for the early 
response. The role of the mast cell in the genesis of the 
late response is more controversial, but the release of 
chemoattractant substances such as leukotrienes and 
cytokines (i.e., interleukin (IL)-3, IL-4, and IL-5) may 
be involved in the influx of neutrophils and eosinophils 
into the airway epithelium. The eosinophil can release 
proteins (e.g., major basic protein, eosinophilic cationic 
protein, eosinophil-derived neurotoxin, and enzymes), 
lipid mediators, and oxygen radicals that can cause 
epithelial injury. There is increasing evidence that 
lymphocytes, especially a CD4+ subset known as TH2 
cells, are involved in the release of cytokines that may 
activate both mast cells (IL-3 and IL-4) and 
eosinophilis (IL-5). In IgE-mediated allergic asthma, 
Th2 cells may be responsible for the maintenance of 
chronic airway inflammation. 
Although the mechanisms by which airway 
inflammation occurs in irritant-induced asthma are not 
well understood, neurogenic pathways may be invo-
lved. The axonal reflex involving C-fiber stimulation 
and the release of neuropeptides have been implicated 
in models of irritant-induced airway inflammation. 
With high-level irritant exposure direct chemical injury 
can lead to an inflammatory response. The important 
unanswered question is what causes this response to 
persist in certain individuals. 
As the senitizer or irritant-induced airway infla-
mmatory process proceeds, mucosal edema, mucus 
secretion, and vascular and epithelial permeability all 
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increase, leading to a reduction of the caliber of the 
airway lumen and resultant airflow obstruction. The 
level of airway obstruction in patients with asthma is a 
marker of the severity of disease. With mild asthma, 
there may be no evidence of obstruction between acute 
exacerbation's, but nonspecific airway hyperrespo-
nsiveness is likely to be present. With more severe 
asthma, there is increased airway hyperresponsiveness 
and airways obstruction is present between attacks. 
Two other mechanisms by which variable airway 
obstruction due to v/orkplace exposure can occur are 
reflex and pharmacological bronchoconstriction. In re-
flex bronchoconstriction, agents such as cold air, dusts, 
mists, vapors, and fumes stimulate neuroreceptors in 
the airway. The reaction does not involve immunology 
mechanisms and does not lead to airway inflammation. 
In most cases, the patient has a history of preexisting 
nonoccupational asthma with nonspecific airway 
hyperesponsiveness so that this is primary mechanism 
of work-aggravated asthma. Pharmacological broncho-
constriction occurs when an agent in the workplace 
causes the direct release of mediators (e.g. Cotton dust 
in textile mills) or a direct effect on the autonomic 
regulation of bronchomotor tone (e.g. Organopho-
sphate pesticides inhibit cholinesterase) (2,6). 
Interestingly, biopsies from patients with atopic 
allergic asthma show very similar histological 
appearances to biopsies from patients with nonallergic 
(intrinsic) asthma (7), from patients with occupational 
asthma due to low molecular weight chemicals, in 
which immunoglobulin E (IgE) is not thought to be 
important (8,9), and even from irritant-induced asthma 
(10). This suggests that the histological appearances of 
allergic inflammation in asthma represent a final 
common response to a variety of inciting agents. 
Despite the huge research effort over the past 10 year, 
there are a number of important questions that remain to 
be answered. Chief among these is the need to establish 
which of the inflammatory changes are primary, and 
which are secondary events, which follow the primary 
insult. Secondly, we need to define which of the 
parameters that we can measure are important to the 
process that initiates asthma, and which are important 
to disease persistence and progression. Some may be 
relevant to both processes while others may operate 
only at certain phases of the disease. Finely, is 
inflammation an essential part of the disease, or are 
there forms of occupational asthma witch have 
different pathophysiological mechanisms and, 
therefore, show different relationships to biomarkers of 
disease severity? 
Diagnosis 
Diagnosis of occupational asthma depends 
greatly on the occupational hystory. Many people with 
occupational asthma have a history of atopy, especially 
when the exposure is to high-molecular-weight 
compounds. However, those without such a history 
may become sensitized after exposure to specific 
environmental agents such as disocyanates. Suspicion 
of this diagnosis should be aroused even when a worker 
has had no previous history of asthma. Often the worker 
reports wheezing, chest tightness, shortness of breath, 
or severe cough developing in the evening or at night 
with recovery overnight or over a weekend away from 
work. However, if exposure and its effects have been 
prolonged, the symptoms may persist at home or over 
the weekend. Specific questioning about nocturnal 
symptoms may elicit responses otherwise not 
volunteered. The physical examination of an acutely ill 
worker reveals wheezing and rhonchi. 
Many patients with occupational asthma have 
normal pulmonary function test results at the time of 
presentation. A particularly useful test for 
bronchoconstriction of occupational origin is the FEV1 
before and after a work shift. A drop of at least 300 mL, 
or 10% of the FEV1 (measured as the mean of the two 
best of three acceptable result each time) between the 
beginning and end of the first shift of the work week 
suggest a work-related effect. An acute drop in FEV1 as 
large as 1,8 L has been measured without the worker 
reporting symptoms. Serial measurements of peak 
flow, such as four times daily, both on days at and days 
away from work, with a simple, inexpensive peak-flow 
meter can be extremely valuable in detecting work-
associated declines in airflow. Peak-flow monitoring 
has also become a mainstay of asthma management. 
Excessive eosinophils in the sputum or blood may 
distinguish asthma from bronchitis. Allergy skin tests 
with common aeroallergens can be used establish 
whether or not the worker is atopic. Atopy is a risk 
factor for high-molecular-weight sensitizer - induced 
asthma. When high-molecular-weight compounds are 
responsible for occupational asthma, skin tests with the 
appropriate extracts may help identify the etiologic 
agent. Extracts of materials such as flour, animal 
proteins, and coffee will give positive skin tests in 
specifically sensitized individuals. Skin testing may 
also be helpful for a few low-molecular-weight 
compounds such as platinum salts. IgE antibodies 
assayed by the radioallergosorbent test (RAST) or by 
enzyme-linked immunoabsorbent assay (ELISA) may 
confirm exposure to allergens such as flour, animal 
proteins, acid anhydrides, plicatic acid, or isocyanates. 
However, the presence of positive skin reactions and/or 
specific antibodies is not always correlated with the 
presence of occupational asthma. Measurement of 
nonspecific bronchial hyperreactivity is carried out by 
bronchial provocation test with histamine or me-
thacholine. Approximately 95% of asthmatic patients 
develop symptoms and significant airflow obstruction 
after inhalation of these agents. Such testing can be 
particularly valuable if it demonstrates an increase in 
airway responsiveness on returning to work or a de-
crease when away from work. The most specific 
diagnostic information is provided by an inhalation 
provocation test using the suspected industrial agent. 
Identifying and purifying the agent, administering into 
the patient, and monitoring the concentration achieved 
are often technically difficult. Provocation tests are 
time consuming and potentially dangerous. Hospita-
lization is advisable, since late reactions can only be 
detected with continuous monitoring, and severe 
broncho&pasm may require urgent treatment. 
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Clinical guidelines for diagnosis of occupational 
asthma have been formulated recently and published 
(11): 
1. Symptoms suggestive of asthma, such as 
wheezing, dyspnea, cough, or chest tightness, which 
are variable or intermittent. 
2. Documentation of significant reversible or 
variable airways obstruction. 
3. Evidence of an association between the pattern 
of airways obstruction and some workplace exposure. 
Anyone of the following types of evidence are suffi-
cient: 
a. Documented workplace exposure to an agent 
known to cause occupational asthma and an association 
between symptoms patterns and work. 
b. Significant work-related changes in spirogram 
or peak flow. 
c. Positive response to bronchial provocation 
testing with agent to which patient is exposed to 
work. 
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PROFESIONALNA ASTMA: KOJI JE MEHANIZAM? 
Mirjana Aranđelović i Jovica Jovanović 
Profesionalna astma se može definisati kao astma izazvana izlaganjem agensu u radnoj 
sredini. Mnogi agensi iz radne sredine su prikazani kao uzročnici astme a njihov broj se stalno 
uvećava sa upotrebom novih materijala i procesa proizvodnje. Postoje dva glavna tipa profe-
sionalne astme. Senzitivno indukovana astma se karakteriše specifičnom preosetljivošću na eti-
ološki agens. Mehanizam iritantno indukovane astme je nepoznat, ali nema kliničkih 
pokazatelja senzibilizacije. Druga dva mehanizma koji dovode do varijabilne opstrukcije di-
sajnih puteva na radnom mestu su refleksna i farmakološka bronhoopstrukcija. Dijagnoza profe-
sionalne astme nije jednostavna. Testovi koji su od pomoći u dijagnostičkom postupku 
uključuju nespecifični i specifični bronhoprovokacioni test, serijsko praćenje plućne funkcije 
(upotrebom peak flow metra) i imunoloski testovi. Nijedan test nije dovoljno specifican. Rana 
dijagnoza profesionalne astme i uklanjanje bolesnika od uzročnog agensa su najvažniji. Acta 
Medico. Medianae 2003; 42 (3): 53-57. 
Ključne reči: profesionalna astma, patofiziologija, dijagnoza, prognoza 